✦ LIBER ✦

Sustained HBeAg and HBsAg Loss After Long-term Follow-up of HBeAg-Positive Patients Treated With Peginterferon α-2b

✍ Scribed by Erik H.C.J. Buster; Hajo J. Flink; Yilmaz Cakaloglu; Krzysztof Simon; Jörg Trojan; Fehmi Tabak; Thomas M.K. So; S. Victor Feinman; Tomasz Mach; Ulus S. Akarca; Martin Schutten; Wanda Tielemans; Anneke J. van Vuuren; Bettina E. Hansen; Harry L.A. Janssen

Book ID: 119760419
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 472 KB
Volume: 135
Category: Article
ISSN: 0016-5085
DOI: 10.1053/j.gastro.2008.05.031

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term follow up of HBeAg positive ch

Long-term follow up of HBeAg positive chronic hepatitis B treated with gamma and beta

✍ Kishida, Y.; Naito, M.; Katayama, K.; Kashiwagi, T.; Yoshihara, H.; Kamada, T.; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 175 KB

P407 HBeAg INDEX AND HBVDNA REDUCTION CA

P407 HBeAg INDEX AND HBVDNA REDUCTION CAN PREDICT LONG TERM RESPONSE OF CHRONIC HEPATITIS B, HBeAg POSITIVE PATIENTS TREATED WITH PEGINTERFERON ALPHA-2a: A THREE-YEAR FOLLOW-UP

✍ Phisalprapa, P.; Charatcharoenwitthaya, P.; Chainuwatti, S.; Chotiyaputta, W.; N 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Use of on-Treatment HBsAg Level and HBeA

Use of on-Treatment HBsAg Level and HBeAg Index Can Early Predict Sustained Virological Response in Chronic Hepatitis B, HBeAg Positive Patients Treated With Peginterferon ALPHA-2A

✍ Phisalprapa, Pochamana ;Charatcharoenwitthaya, Phunchai ;Chainuvati, Siwaporn P. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 570 KB

753 BASELINE HBsAg PREDICTS HBsAg LOSS A

753 BASELINE HBsAg PREDICTS HBsAg LOSS AFTER 2 YEARS OF TREATMENT-FREE FOLLOW-UP IN CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON alfa-2a AND ADEFOVIR

✍ Jansen, L.; Takkenberg, R.B.; de Niet, A.; Zaaijer, H.L.; Weegink, C.J.; Terpstr 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 53 KB

924 INCREASING RATES OF HBsAg CLEARANCE

924 INCREASING RATES OF HBsAg CLEARANCE AND SEROCONVERSION IN PATIENTS WITH HBeAg-NEGATIVE DISEASE TREATED WITH PEGINTERFERON ALFA-2A ± LAMIVUDINE: RESULTS OF 5-YEAR POST-TREATMENT FOLLOW UP

✍ P. Marcellin; T. Piratvisuth; M. Brunetto; F. Bonino; G.K.K. Lau; P. Farci; C. Y 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB

484 On-treatment predictors of sustained

484 On-treatment predictors of sustained biochemical and virological response in patients with HBeAg-negative chronic hepatitis B (CHB) treated with peginterferon α-2a (40 kDa) (PEGASYS®)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 135 KB